GLUC Quote, Financials, Valuation and Earnings

Bridgford Foods Corp. has a net margin of -130.47% compared to Glucose Health, Inc.'s net margin of -3.15%. Glucose Health, Inc.'s return on equity of -- beat Bridgford Foods Corp.'s return on equity of -5.79%.

Glucose Health, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Bridgford Foods Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Glucose Health, Inc. has higher upside potential than Bridgford Foods Corp., analysts believe Glucose Health, Inc. is more attractive than Bridgford Foods Corp..

Glucose Health, Inc. has a beta of 1.591, which suggesting that the stock is 59.065% more volatile than S&P 500. In comparison Bridgford Foods Corp. has a beta of -0.249, suggesting its less volatile than the S&P 500 by 124.925%.

Glucose Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bridgford Foods Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Glucose Health, Inc. pays 5.88% of its earnings as a dividend. Bridgford Foods Corp. pays out -- of its earnings as a dividend. Glucose Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Glucose Health, Inc. quarterly revenues are $58.1K, which are smaller than Bridgford Foods Corp. quarterly revenues of $52M. Glucose Health, Inc.'s net income of -$75.8K is higher than Bridgford Foods Corp.'s net income of -$1.6M. Notably, Glucose Health, Inc.'s price-to-earnings ratio is -- while Bridgford Foods Corp.'s PE ratio is 62.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Glucose Health, Inc. is 8.85x versus 0.29x for Bridgford Foods Corp.. Usually stocks with elevated PS ratios are considered overvalued.

The Hain Celestial Group, Inc. has a net margin of -130.47% compared to Glucose Health, Inc.'s net margin of -5.61%. Glucose Health, Inc.'s return on equity of -- beat The Hain Celestial Group, Inc.'s return on equity of -78.55%.

Glucose Health, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand The Hain Celestial Group, Inc. has an analysts' consensus of $2.41 which suggests that it could grow by 104.56%. Given that The Hain Celestial Group, Inc. has higher upside potential than Glucose Health, Inc., analysts believe The Hain Celestial Group, Inc. is more attractive than Glucose Health, Inc..

Glucose Health, Inc. has a beta of 1.591, which suggesting that the stock is 59.065% more volatile than S&P 500. In comparison The Hain Celestial Group, Inc. has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.35%.

Glucose Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Hain Celestial Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Glucose Health, Inc. pays 5.88% of its earnings as a dividend. The Hain Celestial Group, Inc. pays out -- of its earnings as a dividend. Glucose Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Glucose Health, Inc. quarterly revenues are $58.1K, which are smaller than The Hain Celestial Group, Inc. quarterly revenues of $367.9M. Glucose Health, Inc.'s net income of -$75.8K is higher than The Hain Celestial Group, Inc.'s net income of -$20.6M. Notably, Glucose Health, Inc.'s price-to-earnings ratio is -- while The Hain Celestial Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Glucose Health, Inc. is 8.85x versus 0.07x for The Hain Celestial Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Healthy Choice Wellness Corp. has a net margin of -130.47% compared to Glucose Health, Inc.'s net margin of -3.52%. Glucose Health, Inc.'s return on equity of -- beat Healthy Choice Wellness Corp.'s return on equity of -43.51%.

Glucose Health, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Healthy Choice Wellness Corp. has an analysts' consensus of $2.00 which suggests that it could grow by 660.46%. Given that Healthy Choice Wellness Corp. has higher upside potential than Glucose Health, Inc., analysts believe Healthy Choice Wellness Corp. is more attractive than Glucose Health, Inc..

Glucose Health, Inc. has a beta of 1.591, which suggesting that the stock is 59.065% more volatile than S&P 500. In comparison Healthy Choice Wellness Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Glucose Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthy Choice Wellness Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Glucose Health, Inc. pays 5.88% of its earnings as a dividend. Healthy Choice Wellness Corp. pays out -- of its earnings as a dividend. Glucose Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Glucose Health, Inc. quarterly revenues are $58.1K, which are smaller than Healthy Choice Wellness Corp. quarterly revenues of $20.3M. Glucose Health, Inc.'s net income of -$75.8K is higher than Healthy Choice Wellness Corp.'s net income of -$712.4K. Notably, Glucose Health, Inc.'s price-to-earnings ratio is -- while Healthy Choice Wellness Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Glucose Health, Inc. is 8.85x versus 0.05x for Healthy Choice Wellness Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Laird Superfood, Inc. has a net margin of -130.47% compared to Glucose Health, Inc.'s net margin of -7.56%. Glucose Health, Inc.'s return on equity of -- beat Laird Superfood, Inc.'s return on equity of -14.38%.

Glucose Health, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Laird Superfood, Inc. has an analysts' consensus of $9.67 which suggests that it could grow by 339.39%. Given that Laird Superfood, Inc. has higher upside potential than Glucose Health, Inc., analysts believe Laird Superfood, Inc. is more attractive than Glucose Health, Inc..

Glucose Health, Inc. has a beta of 1.591, which suggesting that the stock is 59.065% more volatile than S&P 500. In comparison Laird Superfood, Inc. has a beta of 2.351, suggesting its more volatile than the S&P 500 by 135.079%.

Glucose Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Laird Superfood, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Glucose Health, Inc. pays 5.88% of its earnings as a dividend. Laird Superfood, Inc. pays out -- of its earnings as a dividend. Glucose Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Glucose Health, Inc. quarterly revenues are $58.1K, which are smaller than Laird Superfood, Inc. quarterly revenues of $12.9M. Glucose Health, Inc.'s net income of -$75.8K is higher than Laird Superfood, Inc.'s net income of -$975.1K. Notably, Glucose Health, Inc.'s price-to-earnings ratio is -- while Laird Superfood, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Glucose Health, Inc. is 8.85x versus 0.48x for Laird Superfood, Inc.. Usually stocks with elevated PS ratios are considered overvalued.